EMITF Elbit Imaging

ELBIT IMAGING LTD. ANNOUNCES THAT INSIGHTEC RECEIVES FDA APPROVAL AND CE MARK FOR EXABLATE NEURO WITH GE SIGNA PREMIER MRI SYSTEM

ELBIT IMAGING LTD. ANNOUNCES THAT INSIGHTEC RECEIVES FDA APPROVAL AND CE MARK FOR EXABLATE NEURO WITH GE SIGNA PREMIER MRI SYSTEM

Tel Aviv, Israel, July 10, 2019 (GLOBE NEWSWIRE) --  Elbit Imaging Ltd. (TASE, OTC US: EMITF) ("Elbit" or the "Company") announced today that Insightec Ltd. ("Insightec") announced today FDA approval and CE mark for Exablate Neuro™ compatible with the SIGNA™ Premier MRI system from GE Healthcare.

Exablate Neuro has FDA approval for the treatment of medication-refractory essential tremor and tremor-dominant Parkinson's disease and CE mark for the treatment of Essential Tremor, Tremor Dominant idiopathic Parkinson’s Disease-Unilateral and neuropathic pain.

The Company holds approximately 62% of the share capital of Elbit Medical Technologies Ltd. (TASE: EMTC-M) (40% on a fully diluted basis) which, in turn, holds approximately 22% of the share capital in Insightec (18% on a fully diluted basis).

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) medical Industries through our indirect holdings in InSightec Ltd. and Gamida Cell Ltd.; (ii) land in India which are designated for sale (and which was initially designated for residential projects).

For Further Information:
Company Contact
Ron Hadassi
CEO and Chairman of the Board of Directors
Tel:  
Fax:
EN
10/07/2019

Underlying

EMITFElbit Imaging

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Elbit Imaging

 PRESS RELEASE
Free
EMITF ELBIT IMAGING

ELBIT IMAGING ANNOUNCES VOLUNTARY SEC DEREGISTRATION

ELBIT IMAGING ANNOUNCES VOLUNTARY SEC DEREGISTRATION Tel Aviv, Israel, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (TASE, OTC US: EMITF) ("Elbit" or the "Company") announced today, that its Board of Directors approved the filing of a Form 15F with the Securities and Exchange Commission ("SEC") to voluntarily deregister its ordinary shares under Section 13(a) and Section 15(d) of the Securities Exchange Act of 1934 (the "Exchange Act"). The Company will file today the Form 15F. The Company's reporting obligations under the Exchange Act will be suspended immediately upon the filing...

August 8, 2019 1 EN
 PRESS RELEASE
Free
EMITF ELBIT IMAGING

ELBIT Imaging Announces Update Regarding the Agreement to Sell Its Hol...

ELBIT Imaging Announces Update Regarding the Agreement to Sell Its Holdings In the Project in Bangalore, India TEL AVIV, Israel, July 25, 2019 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (TASE, OTC US: EMITF) ("Elbit" or the "Company") announced today, further to its press release dated May 27, 2019, regarding an agreement (the "Agreement") signed by Elbit Plaza India Real Estate Holdings Limited (a subsidiary held by the Company (50%) and Plaza Centers N.V. (50%)) ("EPI"), for the sale of a 100% interest in a Special Purpose Vehicle which holds a site in Bangalore, India, to a local investor ...

July 25, 2019 1 EN
 PRESS RELEASE
Free
EMITF ELBIT IMAGING

ELBIT IMAGING LTD. ANNOUNCES THAT INSIGHTEC RECEIVES FDA APPROVAL AND ...

ELBIT IMAGING LTD. ANNOUNCES THAT INSIGHTEC RECEIVES FDA APPROVAL AND CE MARK FOR EXABLATE NEURO WITH GE SIGNA PREMIER MRI SYSTEM Tel Aviv, Israel, July 10, 2019 (GLOBE NEWSWIRE) --  Elbit Imaging Ltd. (TASE, OTC US: EMITF) ("Elbit" or the "Company") announced today that Insightec Ltd. ("Insightec") announced today FDA approval and CE mark for Exablate Neuro™ compatible with the SIGNA™ Premier MRI system from GE Healthcare. Exablate Neuro has FDA approval for the treatment of medication-refractory essential tremor and tremor-dominant Parkinson's disease and CE mark for the treatment...

July 10, 2019 1 EN
 PRESS RELEASE
Free
EMITF ELBIT IMAGING

ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL ANNOUNCES FULL EXERCISE OF UN...

ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL ANNOUNCES FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES Tel Aviv, Israel, July 08, 2019 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (TASE, UTC UC: EMITF) (“Elbit” or the “Company”) announced today, further to its press release dated June 27, 2019 that Gamida Cell Ltd. (Nasdaq: GMDA) (“Gamida”), an indirect shareholding of the Company announced that the underwriters of its recently closed underwritten public offering of 7,000,000 ordinary shares have exercised in full their option to purchase an additional 1,050,000 ordinary shares ...

July 8, 2019 1 EN
 PRESS RELEASE
Free
EMITF ELBIT IMAGING

ELBIT IMAGING ANNOUNCES RECEIVING FIRST INTEREST PAYMENT UNDER THE VEN...

ELBIT IMAGING ANNOUNCES RECEIVING FIRST INTEREST PAYMENT UNDER THE VENDOR LOAN GIVEN TO THE RADISSON HOTEL PURCHASER Tel Aviv, Israel, July 03, 2019 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (TASE, UTC UC: EMITF) (“Elbit” or the “Company”) announced today, further to its press releases dated December 18, 2017 and April 2, 2019 regarding the sale of its holdings in a SPV that holds the Radisson Hotel Complex in Bucharest, Romania (the "Agreement"), in which the Company has granted to the hotel's purchaser (the "Purchaser") a vendor loan of €8 million (the "Vendor Loan"), that the Purchaser ha...

July 3, 2019 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch